The large benefits consultants who advise employers on their health care plans for employees have consistently warned of higher costs in this year and the next year. Mercer has weighed in with expectations of 5% plus health plan cost inflation for 2023. This was very predicatable because the epidemic has caused substantial cost of doing business increases for health care providers, including labor and supply costs, and those providers will feel a need to pass those increases along to health plans. Providers generally have the market power to aid them in doing so. Drug companies can always be counted on to rapidly raise their prices. When health plans pay more for services and goods from health care providers, they have to increase premiums or risk losing money. So both the raw prices for health care services and the health plan premiums are rising. The official inflation numbers account for this in goofy ways, but sooner or later it has to be recognized and it is a significant cost for many Americans. The underlying health care inflation also affects government spending in Medicare and Medicaid, further increasing our deficits. (Mercer Survey)
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Two health care firms owned by private equity firms are merging in a transaction supposedly valued at $3 billion. HealthComp administers self-funded plans for employers and other groups and Virgin...
September 27, 2023
NextGen, an electronic medical records firm, is being put out of its public company misery, as a PE firm will pay $1.6 billion for the one-time high-flier.
September 7, 2023
A number of companies which attracted large financing rounds during the epidemic have imploded when reality set in. The latest is Cano Health, which is a little surprising since it...
August 15, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace